0 XP   0   0   0

Acurx Pharmaceuticals LLC
Buy or Sell?

I guess you are interested in Acurx Pharmaceuticals LLC. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's start. I'm going to help you getting a better view of Acurx Pharmaceuticals LLC. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Acurx Pharmaceuticals LLC even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Acurx Pharmaceuticals LLC is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Acurx Pharmaceuticals LLC. The closing price on 2022-09-23 was $3.03 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Daily chart of Acurx Pharmaceuticals LLC
Acurx Pharmaceuticals LLC Daily Candlestick Chart

1.1. Profitability of Acurx Pharmaceuticals LLC.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin
  • Measures how much profit a company generates for each dollar of revenue.
  • Above 10% is considered healthy depending on the industry.
  • A net profit margin of 25% means that $0,25 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Acurx Pharmaceuticals LLC:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--242.4%+242.4%
TTM--275.9%+275.9%
YOY--328.0%+328.0%
5Y--464.6%+464.6%
10Y--547.1%+547.1%
1.1.2. Return on Assets
  • Shows how profitable a company is in relation to its total assets.
  • Above 5% is considered healthy depending on the industry.
  • 5% return on assets means the company generated $0,05 for each $1 in assets.

Let's take a look of the Return on Assets trends of Acurx Pharmaceuticals LLC:

  • The MRQ is -28.3%. Very bad. -2
  • The TTM is -35.5%. Very bad. -2
Trends
Current periodCompared to+/- 
MRQ-28.3%TTM-35.5%+7.2%
TTM-35.5%YOY-35.4%0.0%
TTM-35.5%5Y-35.5%0.0%
5Y-35.5%10Y-35.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-28.3%-9.8%-18.5%
TTM-35.5%-8.8%-26.7%
YOY-35.4%-9.2%-26.2%
5Y-35.5%-11.6%-23.9%
10Y-35.5%-12.7%-22.8%
1.1.3. Return On Equity
  • Measures the profit in relation to shareholders equity (total assets - total liabilities).
  • Above 15%-20% is considered healthy depending on the industry
  • 10% return on equity means the company generated $0,1 for each $1 the owners (shareholders) invested.

Let's take a look of the Return On Equity trends of Acurx Pharmaceuticals LLC:

  • The MRQ is -29.8%. Very bad. -2
  • The TTM is -37.6%. Very bad. -2
Trends
Current periodCompared to+/- 
MRQ-29.8%TTM-37.6%+7.8%
TTM-37.6%YOY-42.0%+4.4%
TTM-37.6%5Y-39.5%+1.9%
5Y-39.5%10Y-39.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-29.8%-11.9%-17.9%
TTM-37.6%-11.2%-26.4%
YOY-42.0%-10.6%-31.4%
5Y-39.5%-13.7%-25.8%
10Y-39.5%-14.5%-25.0%

1.2. Operating Efficiency of Acurx Pharmaceuticals LLC.

1.2. Operating Efficiency
1.2.1. Operating Margin
  • Measures how much profit a company makes for each $1 of sales after paying variable costs (production costs, wages) but before taxes.
  • Above 15% is considered healthy depending on the industry
  • An operating margin of 20% means the company generated $0,2 for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Acurx Pharmaceuticals LLC:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--232.1%+232.1%
TTM--269.6%+269.6%
YOY--306.8%+306.8%
5Y--461.8%+461.8%
10Y--546.8%+546.8%
1.2.2. Operating Ratio
  • Measures how efficient the company is creating its products or services while keeping operating costs low.
  • Below 1 is considered healthy depending on the industry
  • An operation ratio of 0.5 means that the operating costs are $0,5 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Acurx Pharmaceuticals LLC:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.321-3.321
TTM-3.662-3.662
YOY-3.692-3.692
5Y-5.743-5.743
10Y-6.919-6.919

1.3. Liquidity of Acurx Pharmaceuticals LLC.

1.3. Liquidity
1.3.1. Current Ratio
  • Measures if the company is able to pay off short-term debts (debts due within 1 year).
  • Above 1 is considered healthy depending on the industry.
  • A current ratio of 1.5 means the company has $1.5 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Acurx Pharmaceuticals LLC:

  • The MRQ is 19.433. Very Good. +2
  • The TTM is 18.429. Very Good. +2
Trends
Current periodCompared to+/- 
MRQ19.433TTM18.429+1.005
TTM18.429YOY7.216+11.213
TTM18.4295Y13.623+4.806
5Y13.62310Y13.6230.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ19.4335.318+14.115
TTM18.4296.219+12.210
YOY7.2166.366+0.850
5Y13.6236.760+6.863
10Y13.6236.520+7.103
1.3.2. Quick Ratio
  • Measures if the company is able to pay short-term debts (debts due within 1 year). But only uses the most liquid assets (cash, marketable securities and accounts retrievable).
  • Above 1 is considered healthy depending on the industry.
  • A quick ratio of 0,8 means the company can pay off $0,8 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Acurx Pharmaceuticals LLC:

  • The MRQ is 19.187. Very good. +2
  • The TTM is 13.013. Very good. +2
Trends
Current periodCompared to+/- 
MRQ19.187TTM13.013+6.174
TTM13.013YOY5.210+7.803
TTM13.0135Y9.669+3.344
5Y9.66910Y9.6690.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ19.1874.101+15.086
TTM13.0134.994+8.019
YOY5.2105.256-0.046
5Y9.6695.338+4.331
10Y9.6695.050+4.619

1.4. Solvency of Acurx Pharmaceuticals LLC.

1.3. Liquidity
1.4.1. Debt To Asset Ratio
  • Shows if the company is owned by creditors or shareholders.
  • Below 1 (100%) is considered healthy depending on the industry
  • A debt to asset ratio of 0.45 (45%) means that the company is financed with 45% credit and 55% is financed by it's owners (shareholders).

Let's take a look of the Debt To Asset Ratio trends of Acurx Pharmaceuticals LLC:

  • The MRQ is 0.051. Very good. +2
  • The TTM is 0.055. Very good. +2
Trends
Current periodCompared to+/- 
MRQ0.051TTM0.055-0.003
TTM0.055YOY0.148-0.093
TTM0.0555Y0.095-0.040
5Y0.09510Y0.0950.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0510.269-0.218
TTM0.0550.267-0.212
YOY0.1480.297-0.149
5Y0.0950.362-0.267
10Y0.0950.398-0.303
1.4.2. Debt to Equity Ratio
  • Measures the total debt versus the total shareholders equity (total assets - total liabilities).
  • Below 2 is considered healthy depending on the industry.
  • A debt to equity ratio of 0.84 means that company has $0,84 debt for each $1 in equity.

Let's take a look of the Debt to Equity Ratio trends of Acurx Pharmaceuticals LLC:

  • The MRQ is 0.054. Very good. +2
  • The TTM is 0.058. Very good. +2
Trends
Current periodCompared to+/- 
MRQ0.054TTM0.058-0.004
TTM0.058YOY0.175-0.117
TTM0.0585Y0.108-0.050
5Y0.10810Y0.1080.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0540.305-0.251
TTM0.0580.303-0.245
YOY0.1750.309-0.134
5Y0.1080.382-0.274
10Y0.1080.436-0.328

2. Market Valuation of Acurx Pharmaceuticals LLC

2. Earnings
2.1. Price to Earnings Ratio
  • Compares the company's stock price to its earnings.
  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of 15 means the investor is paying $15 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Acurx Pharmaceuticals LLC:

  • The EOD is -2.242. Company is losing money. -2
  • The MRQ is -2.804. Company is losing money. -2
  • The TTM is -2.875. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-2.242MRQ-2.804+0.562
MRQ-2.804TTM-2.875+0.071
TTM-2.875YOY--2.875
TTM-2.8755Y-1.643-1.232
5Y-1.64310Y-1.6430.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.242-2.088-0.154
MRQ-2.804-2.275-0.529
TTM-2.875-3.793+0.918
YOY--4.994+4.994
5Y-1.643-3.642+1.999
10Y-1.643-3.303+1.660

2. Books
2.3. Price to Book Ratio
  • Shows if the stock is under or overvalued compared to it's book value (total assets - total liabilities).
  • At or below 1 is considered healthy
  • A PB ratio of 3 means the investor is paying $3 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Acurx Pharmaceuticals LLC:

  • The EOD is 3.540. Neutral. Compare to industry.
  • The MRQ is 4.428. Neutral. Compare to industry.
  • The TTM is 3.410. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
EOD3.540MRQ4.428-0.888
MRQ4.428TTM3.410+1.018
TTM3.410YOY0.955+2.455
TTM3.4105Y2.358+1.052
5Y2.35810Y2.3580.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.5401.808+1.732
MRQ4.4281.944+2.484
TTM3.4102.750+0.660
YOY0.9553.490-2.535
5Y2.3582.731-0.373
10Y2.3582.401-0.043

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Acurx Pharmaceuticals LLC.

3.1. Institutions holding Acurx Pharmaceuticals LLC

Institutions are holding 3.083% of the shares of Acurx Pharmaceuticals LLC.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-03-31Draper Asset Management, LLC2.5920.72162660252660250
2022-03-31Geode Capital Management, LLC0.1066010941109410
2022-03-31Tocqueville Asset Management L.P.0.09840.000510100-15000-59.761
2022-03-31Patriot Financial Group Insurance Agency, LLC0.0950.00579750275039.2857
2022-06-30Semmax Financial Advisors Inc.0.05730.011458794616365.479
2022-03-31Tower Research Capital LLC0.03230.0001331933190
2022-03-31Wells Fargo & Co0.000201600
2022-03-31Millennium Management LLC000-13949-100
2022-03-31Advisor Group Holdings, Inc.000-5000-100
2022-03-31HRT FINANCIAL LLC000-14369-100
Total 2.98180.7393306030  

3.2. Funds holding Acurx Pharmaceuticals LLC

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-07-29iShares Micro-Cap ETF0.13940.00541430200
2022-06-30Fidelity® NASDAQ Composite Index®0.08460.0003868300
2022-07-31Vanguard Total Stock Mkt Idx Inv0.044104521139544.6257
2022-06-30Fidelity® Series Total Market Index0.0220225800
2022-06-30Northern Trust Extended Eq Market Idx0.01870.0002191500
2022-06-30NT Ext Equity Mkt Idx Fd - L0.01870.0002191500
2022-06-301290 VT Micro Cap K0.01470.0038150800
2022-06-30USAA Extended Market Index0.01130.00061155-1-0.0865
2022-07-31State St US Extended Mkt Indx NL Cl C0.01070.0002110000
2022-06-30SSgA U.S. Extended Market Index Class I0.01070.0002110000
2022-06-30Spartan Total Market Index Pool E0.005805945940
2022-06-30SSgA U.S. Total Market Index Strategy0.00330339144.3077
Total 0.3840.010939390  

3.3. Insider Transactions

Insiders are holding 21.496% of the shares of Acurx Pharmaceuticals LLC.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-07-27Carl SailerBUY197373.892815
2022-07-27Carl SailerBUY197373.892815
2022-07-27Carl SailerBUY197373.892815
2022-07-27Carl SailerBUY197373.892815
2022-07-27Carl SailerBUY197373.892815
2022-07-27Carl SailerBUY197373.892815
2022-07-27Carl SailerBUY197373.892815
2022-07-27Carl SailerBUY197373.892815
2022-07-27Carl SailerBUY197373.892815
2022-07-27Carl SailerBUY197373.892815
2022-07-27Carl SailerBUY197373.892815
2022-07-27Carl SailerBUY197373.892815
2022-07-27Carl SailerBUY197373.892815
2022-07-27Carl SailerBUY197373.892815
2022-07-27Carl SailerBUY197373.892815
2022-07-27Carl SailerBUY197373.892815
2022-07-27Carl SailerBUY197373.892815
2022-07-27Carl SailerBUY197373.892815
2022-07-27Carl SailerBUY197373.892815
2022-07-27Carl SailerBUY197373.892815

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Acurx Pharmaceuticals LLC compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share--0.8561.273-33%0.923-7%1.123-24%1.123-24%
Current Ratio--19.43318.429+5%7.216+169%13.623+43%13.623+43%
Debt To Asset Ratio--0.0510.055-6%0.148-65%0.095-46%0.095-46%
Debt To Equity Ratio--0.0540.058-7%0.175-69%0.108-50%0.108-50%
Eps---0.255-0.338+32%-0.279+9%-0.312+22%-0.312+22%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio3.540-25%4.4283.410+30%0.955+364%2.358+88%2.358+88%
Pe Ratio-2.242+20%-2.804-2.875+3%--100%-1.643-41%-1.643-41%
Price Per Share3.030-25%3.7904.133-8%2.127+78%3.273+16%3.273+16%
Quick Ratio--19.18713.013+47%5.210+268%9.669+98%9.669+98%
Return On Assets---0.283-0.355+25%-0.354+25%-0.355+25%-0.355+25%
Return On Equity---0.298-0.376+26%-0.420+41%-0.395+32%-0.395+32%
 EOD+2 -1MRQTTM+8 -3YOY+8 -35Y+8 -310Y+8 -3

4.2. Fundamental Score

Let's check the fundamental score of Acurx Pharmaceuticals LLC based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.242
Price to Book Ratio (EOD)Between0-13.540
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than119.187
Current Ratio (MRQ)Greater than119.433
Debt To Asset Ratio (MRQ)Less than10.051
Debt to Equity Ratio (MRQ)Less than10.054
Return On Equity (MRQ)Greater than0.15-0.298
Return on Assets (MRQ)Greater than0.05-0.283
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Acurx Pharmaceuticals LLC based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.063
Ma 20Greater thanMa 503.686
Ma 50Greater thanMa 1003.814
Ma 100Greater thanMa 2003.536
OpenGreater thanClose3.210
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets9,259
Total Liabilities474
Total Stockholder Equity8,785
 As reported
Total Liabilities 474
Total Stockholder Equity+ 8,785
Total Assets = 9,259

Assets

Total Assets9,259
Total Current Assets9,209
Long-term Assets9,209
Total Current Assets
Cash And Cash Equivalents 9,092
Other Current Assets 117
Total Current Assets  (as reported)9,209
Total Current Assets  (calculated)9,209
+/-0
Long-term Assets
Other Assets 50
Long-term Assets  (as reported)50
Long-term Assets  (calculated)50
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities474
Long-term Liabilities0
Total Stockholder Equity8,785
Total Current Liabilities
Accounts payable 474
Other Current Liabilities 474
Total Current Liabilities  (as reported)474
Total Current Liabilities  (calculated)948
+/- 474
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock10
Retained Earnings -31,839
Other Stockholders Equity 40,614
Total Stockholder Equity (as reported)8,785
Total Stockholder Equity (calculated)8,785
+/-0
Other
Capital Stock10
Cash and Short Term Investments 9,092
Common Stock Shares Outstanding 10,263
Liabilities and Stockholders Equity 9,259
Net Debt -9,092
Net Invested Capital 8,785
Net Tangible Assets 8,785
Net Working Capital 8,735



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-06-302020-03-31
> Total Assets 
0
0
3,224
2,982
17,440
14,990
13,254
11,322
9,259
9,25911,32213,25414,99017,4402,9823,22400
   > Total Current Assets 
0
0
3,224
2,642
17,440
14,990
12,959
11,322
9,209
9,20911,32212,95914,99017,4402,6423,22400
       Cash And Cash Equivalents 
0
0
3,175
2,628
17,096
14,459
12,959
11,083
9,092
9,09211,08312,95914,45917,0962,6283,17500
       Other Current Assets 
0
0
49
0
345
0
0
239
117
1172390034504900
   > Long-term Assets 
0
0
0
339
0
0
0
0
50
500000339000
       Other Assets 
0
0
0
339
0
0
295
239
50
5023929500339000
> Total Liabilities 
0
0
522
511
1,919
712
844
633
474
4746338447121,91951152200
   > Total Current Liabilities 
0
0
473
461
1,919
712
844
633
474
4746338447121,91946147300
       Short-term Debt 
0
0
17
0
0
0
0
0
0
0000001700
       Short Long Term Debt 
0
0
17
17
0
0
0
0
0
00000171700
       Accounts payable 
0
0
0
0
97
12
844
633
474
47463384412970000
       Other Current Liabilities 
0
0
456
0
1,919
0
844
633
474
47463384401,919045600
   > Long-term Liabilities 
0
0
50
50
0
0
0
0
0
00000505000
       Deferred Long Term Liability 
0
0
0
339
0
0
0
0
50
500000339000
> Total Stockholder Equity
0
0
2,702
2,471
15,522
14,277
12,410
10,689
8,785
8,78510,68912,41014,27715,5222,4712,70200
   Common Stock
0
0
16,502
17,746
10
10
10
10
10
101010101017,74616,50200
   Retained Earnings Total Equity000000000
   Accumulated Other Comprehensive Income 000000000
   Capital Surplus 000000000
   Treasury Stock000000000
   Other Stockholders Equity 
0
0
0
0
34,791
0
38,948
39,897
40,614
40,61439,89738,948034,7910000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-12,814
Operating Income-12,814-12,814
 
Operating Expense (+$)
Research Development2,030
Selling General Administrative10,784
Selling And Marketing Expenses-
Operating Expense12,81412,814
 
Net Interest Income (+$)
Interest Income-
Interest Expense--
Net Interest Income-0
 
Pretax Income (+$)
Operating Income-12,814
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-12,748-12,881
EBIT - interestExpense = -12,814
-12,748
-12,748
Interest Expense-
Earnings Before Interest and Taxes (ebit)-12,814-12,748
Earnings Before Interest and Taxes (ebitda)-12,748
 
After tax Income (+$)
Income Before Tax-12,748
Tax Provision--
Net Income From Continuing Ops-12,748-12,748
Net Income-12,748
Net Income Applicable To Common Shares-12,748
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net670
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
DAAPL.CC
8 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of DAAPL.CC.

DAAPL.CC Daily Candlestick Chart
UIP.CC
8 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of UIP.CC.

UIP.CC Daily Candlestick Chart
TRC.CC
8 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of TRC.CC.

TRC.CC Daily Candlestick Chart
TIX.CC
8 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of TIX.CC.

TIX.CC Daily Candlestick Chart
THC.CC
8 hours ago

I found you a MACD Bearish Reversal Divergence on the daily chart of THC.CC.

THC.CC Daily Candlestick Chart
TERC.CC
8 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of TERC.CC.

TERC.CC Daily Candlestick Chart
RENTBERRY.CC
8 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of RENTBERRY.CC.

RENTBERRY.CC Daily Candlestick Chart
TBTC.CC
8 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of TBTC.CC.

TBTC.CC Daily Candlestick Chart
SWACE.CC
8 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SWACE.CC.

SWACE.CC Daily Candlestick Chart
START.CC
8 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of START.CC.

START.CC Daily Candlestick Chart
SNC.CC
8 hours ago

I found you a Death Cross on the daily chart of SNC.CC.

SNC.CC Daily Candlestick Chart
SAVG.CC
8 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of SAVG.CC.

SAVG.CC Daily Candlestick Chart
RPZX.CC
8 hours ago

I found you a Golden Cross on the daily chart of RPZX.CC.

RPZX.CC Daily Candlestick Chart
RIO.CC
8 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of RIO.CC.

RIO.CC Daily Candlestick Chart
PYRK.CC
8 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of PYRK.CC.

PYRK.CC Daily Candlestick Chart
PLAY.CC
8 hours ago

I found you a MACD Bullish Hidden Divergence on the daily chart of PLAY.CC.

PLAY.CC Daily Candlestick Chart
pBTC35A.CC
8 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of pBTC35A.CC.

pBTC35A.CC Daily Candlestick Chart
PBTC.CC
8 hours ago

I found you a MACD Bearish Reversal Divergence on the daily chart of PBTC.CC.

PBTC.CC Daily Candlestick Chart
PASC.CC
8 hours ago

I found you a Golden Cross on the daily chart of PASC.CC.

PASC.CC Daily Candlestick Chart
OPCT.CC
8 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of OPCT.CC.

OPCT.CC Daily Candlestick Chart
NCDT.CC
8 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NCDT.CC.

NCDT.CC Daily Candlestick Chart
MSWAP.CC
8 hours ago

I found you a Death Cross on the daily chart of MSWAP.CC.

MSWAP.CC Daily Candlestick Chart
MERI.CC
8 hours ago

I found you a MACD Bearish Reversal Divergence on the daily chart of MERI.CC.

MERI.CC Daily Candlestick Chart
MBC.CC
8 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of MBC.CC.

MBC.CC Daily Candlestick Chart